NUFARM LIMITED (NUF)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

NUF

NUF - NUFARM LIMITED

FNArena Sector : Agriculture
Year End: September
GICS Industry Group : Materials
Debt/EBITDA: 3.53
Index: ASX200 | ASX300 | ALL-ORDS

Nufarm is an Australian agricultural chemicals company with manufacturing and marketing operations in Australia, Asia, Europe and North America. First established in 1956, it became a listed company in 1988.

LAST PRICE CHANGE +/- CHANGE % VOLUME

$2.56

11 Aug
2025

0.000

OPEN

$2.56

0.000

HIGH

$2.56

0

LOW

$2.56

TARGET
$3.222 25.8% upside
OTHER COMPANIES IN THE SAME SECTOR
AAC . AMN . APC . CBO . CXM . D2O . ELD . GNC . HFR . LGL . RIC . SGLLV . SHV . TFL . WLD .
FNARENA'S MARKET CONSENSUS FORECASTS
NUF: 1
Title FY23
Actual
FY24
Actual
FY25
Forecast
FY26
Forecast
EPS (cps) xxx - 6.8 1.5 xxx
DPS (cps) xxx 4.0 0.0 xxx
EPS Growth xxx N/A N/A xxx
DPS Growth xxx - 60.0% N/A xxx
PE Ratio xxx N/A 173.0 xxx
Dividend Yield xxx N/A 0.0% xxx
Div Pay Ratio(%) xxx N/A N/A xxx

Dividend yield today if purchased 3 years ago: 0.77%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

1.56

Estimated Dividend Growth
(Average Of Past Three Years)

 %

Amount Invested

Tell Me The Dividend After This Many Years

Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 29/05 - (franking ex-di

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2025 FactSet UK Limited. All rights reserved
Title 201920202021202220232024
EPS Basic xxxxxxxxxxxxxxx-6.8
DPS All xxxxxxxxxxxxxxx4.0
Sales/Revenue xxxxxxxxxxxxxxx3,345.9 M
Book Value Per Share xxxxxxxxxxxxxxx513.8
Net Operating Cash Flow xxxxxxxxxxxxxxx472.4 M
Net Profit Margin xxxxxxxxxxxxxxx-0.17 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 201920202021202220232024
Return on Capital Employed xxxxxxxxxxxxxxx-1.29 %
Return on Invested Capital xxxxxxxxxxxxxxx-0.17 %
Return on Assets xxxxxxxxxxxxxxx-0.12 %
Return on Equity xxxxxxxxxxxxxxx-0.25 %
Return on Total Capital xxxxxxxxxxxxxxx2.87 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx291.9 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 201920202021202220232024
Short-Term Debt xxxxxxxxxxxxxxx82 M
Long Term Debt xxxxxxxxxxxxxxx1,016 M
Total Debt xxxxxxxxxxxxxxx1,098 M
Goodwill - Gross xxxxxxxxxxxxxxx392 M
Cash & Equivalents - Generic xxxxxxxxxxxxxxx464 M
Price To Book Value xxxxxxxxxxxxxxx0.77

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 201920202021202220232024
Capex xxxxxxxxxxxxxxx253.0 M
Capex % of Sales xxxxxxxxxxxxxxx7.56 %
Cost of Goods Sold xxxxxxxxxxxxxxx2,451 M
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx796 M
Research & Development xxxxxxxxxxxxxxx54 M
Investments - Total xxxxxxxxxxxxxxx64 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.0

No. Of Recommendations

6
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Citi

xx/xx/xxxx

5

xxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Bell Potter

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Macquarie

xx/xx/xxxx

3

xxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Morgans

23/05/2025

3

Downgrade to Hold from Add

$2.78

8.59%

Morgans notes Nufarm's 1H25 results were below consensus, with a full-year loss now looking likely.

The main disappointment was the underperformance of the Seed Technologies business, and with the company putting it under review, the broker is thinking of various options.

Selling Seed Tech in full or in part may not lead to a good outcome, the broker reckons, as investors will be left with a stake in the lower quality remaining part of the business.

If it doesn't sell, a large and highly dilutive capital raising could become necessary, especially if operating conditions do not improve. The broker lowered FY25-27 EBITDA forecasts by -20%, -19% and -17%, respectively.

Rating downgraded to Hold from Add. Target price cut to $2.78 from $4.53.

FORECAST
Morgans forecasts a full year FY25 dividend of 0.00 cents and EPS of minus -2.00 cents.
Morgans forecasts a full year FY26 dividend of 0.00 cents and EPS of 9.00 cents.

Morgan Stanley

xx/xx/xxxx

3

xxxxx-xxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

UBS

xx/xx/xxxx

3

xxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

0

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

NUF STOCK CHART